In response to recent heavy criticism received by the FDA, the FDA unveiled a new set of codes on Tuesday hoping to upgrade the safety operations found in the US. The FDA as of late has been plagued with the failure and withdrawal of several high profile drugs, the most popular being Vioxx. Some of the recommendations include a new program to assess the safety of drugs once they are released on the market and a new system to improve communication both inside and outside the troubled agency. According to the article written by Healthday, the FDA Commissioner, Dr. Andrew C. von Eschenbach, told reporters at a news conference, "The world is changing, so the FDA must change to continually achieve progress in its ability to determine the safety and effectiveness of the pr View the rest of this article
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment